Indian finance news saw a flurry of key developments, ranging from fresh IPO announcements and major shareholder stake sales to trade policy warnings and regulatory shifts. From e-commerce and logistics to insurance and forex reserves, several important updates are shaping today's financial updates.

Shiprocket's Rs 1,617.5 Crore IPO to Open August 12

Temasek-backed e-commerce enablement platform Shiprocket has fixed a price band of Rs 92-97 per share for its Rs 1,617.5 crore initial public offering, which will open for subscription on August 12 and close on August 14, with anchor investor bidding scheduled for August 11. The issue comprises a fresh issue of shares worth up to Rs 885.5 crore and an offer for sale of up to Rs 732 crore by existing shareholders including Lightrock, Tribe Capital and Moore Strategic Ventures. Shiprocket reported revenue of Rs 2,077.42 crore for FY26, up 24% year-on-year, though it remained loss-making with a net loss of Rs 79.25 crore during the period. Saahil Goel, Co-founder and CEO, Shiprocket stated, "Non-shipping services like cross-border tools and checkout software drive over a quarter of total revenue and are growing three times faster than core logistics."

Brookfield-Controlled BIF IV Jarvis India Set for Large OFS

Brookfield-controlled BIF IV Jarvis India is set to be the largest seller in an upcoming offer for sale, proposing to offload up to 18.86 crore shares, in what is expected to be one of the more closely watched block transactions in the market this week.

GTRI Warns of Up to 100% US Tariffs Over Russian Oil Purchases

Think tank Global Trade Research Initiative (GTRI) warned that the US Senate's approval of a bill on Russia sanctions could expose Indian exports to additional tariffs of up to 100% if India continues buying Russian crude oil. Russia supplied 30.3% of India's crude imports in FY2026, worth $40.8 billion, helping reduce import costs and contain inflation. GTRI Founder Ajay Srivastava said India should not allow tariff threats to determine its energy policy, stating, "As long as Russian crude remains commercially attractive, India should continue buying it. Differences with Washington must be managed through firm negotiation - not extending unilateral concessions that raise India's energy costs and weaken its strategic autonomy."

RBI's Forex Intervention Saw Net Sale of $14.9 Billion

According to the latest data available from the RBI, the central bank's foreign exchange intervention during January-May 2026 amounted to a net sale of $14.9 billion, the Minister of State for Finance informed Parliament, reflecting the RBI's continued efforts to manage rupee volatility amid global uncertainty.

Supreme Court Extends Mandatory Insurance Cover for New Vehicles

The Supreme Court has extended mandatory third-party insurance cover for new cars to four years and for two-wheelers to six years, "in the interest of road safety." The court noted that with vehicles remaining uninsured beyond the earlier mandated period, accident victims and their families often had no recourse to adequate compensation.

FPIs Remain Net Sellers in Indian Equities Despite Recent Inflows

Foreign portfolio investors have continued to be net sellers in the Indian stock market through the year, despite recent inflows in select sessions, reflecting a cautious overall stance from overseas investors even as domestic market sentiment has shown pockets of resilience.

Taxation and Other Laws (Amendment) Bill, 2026 Moves Forward

The Taxation and Other Laws (Amendment) Bill, 2026, which amends the Payment and Settlement Systems Act, 2007, the Income-tax Act, 2025, and the Finance Act, 2026, continues to progress through Parliament, with the government aiming to formalise tax reforms and enable merchant charges on UPI transactions in the coming weeks.

Milky Mist Dairy Foods Fixes IPO Price Band at Rs 133-140

Milky Mist Dairy Foods has fixed its IPO price band at Rs 133-140 per share, seeking a valuation of Rs 10,775 crore, with the issue set to open shortly as part of a busy primary market pipeline this month.

Molbio Diagnostics Sets IPO Price Band at Rs 768-807

Temasek and Motilal Oswal-backed Molbio Diagnostics has fixed its IPO price band at Rs 768-807 per share, adding to the wave of fresh listings entering India's primary markets in August.

Also Read: India Finance Today: Top Corporate and Market Updates

Market Outlook

With a packed IPO calendar led by Shiprocket, Milky Mist and Molbio Diagnostics, continued FPI caution, and fresh trade policy risks emerging from Washington's Russia sanctions bill, Indian markets are likely to stay in a watchful mode this week. Investors will also track further developments on the RBI's forex management and the passage of the Taxation and Other Laws (Amendment) Bill through Parliament for clarity on near-term policy direction.